Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension
Launched by ABBOTT · May 19, 2010
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
Follow-up of patients enables 4 patient visits during this period. For these reasons, the most likely visits are defined as "Inclusion visit" at which treatment with Tarka® is to be initiated, and then "Follow-up visit Week 4-6", "Follow-up visit Month 3 " and "Follow-up visit Month 6", although dates will depend only on the decision of the physician. For these reasons, the most likely visits are defined as "S/V" (Screening Visit), "F1" (Follow-up 1), "F2" (Follow-up 2), "F3" (Follow-up 3). The end point is compliance with Tarka® treatment by number/percentage of patients continued on fixed...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men, women more than 18 years
- • Patients with uncontrolled essential hypertension eligible to Tarka treatment according to local label (BP ≥ 140/90 mmHg)
- • Patients providing oral informed consent (including consent of their medical data to be used for a Post Marketing Observational Study) and cooperating with physician
- • Patients who never received Tarka® in the past
- • Patients whom Tarka® will be prescribed according to the labelled indication and dose
- Exclusion Criteria:
- * Patients contraindicated for treatment of Tarka® according to the local Summary of Product Characteristics (SmPC):
- • Hypersensitive to the active substances or to any of the inactive ingredients
- • With cardiogenic shock
- • With second and third degree atrioventricular block - except in patients with a functioning artificial pacemaker
- • With sick sinus syndrome - except in patients with a functioning artificial pacemaker
- • With atrial fibrillation/flutter and concomitant Wolff-Parkinson-White syndrome
- • With existing history of angioedema associated with administration of an ACE inhibitor
- • With severe renal (creatinine clearance \< 10 ml/min) or severe liver impairment (cirrhosis with ascites)
- • Pregnant women, women of childbearing potential who are unwilling to use contraception
- • Lactating women
- • Patients who have participated in clinical studies within the last month or who are currently enrolled in clinical studies
- • Patients currently treated with other fixed antihypertensive combination
About Abbott
Abbott is a global healthcare company dedicated to improving lives through innovative medical technologies, diagnostics, nutrition, and branded generic pharmaceuticals. With a commitment to advancing health and wellness, Abbott conducts clinical trials to evaluate the safety and efficacy of its diverse portfolio of products, which span multiple therapeutic areas, including cardiovascular, diabetes care, and neurology. The company employs rigorous research methodologies and collaborates with healthcare professionals and institutions worldwide to ensure the highest standards of clinical integrity and patient safety. Abbott's mission is to deliver impactful solutions that enhance patient outcomes and contribute to the advancement of global healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Babice, , Czech Republic
Beroun, , Czech Republic
Bilovec, , Czech Republic
Blansko, , Czech Republic
Brandys Nad Labem, , Czech Republic
Breclav, , Czech Republic
Brno, , Czech Republic
Brno, , Czech Republic
Brno, , Czech Republic
Brno, , Czech Republic
Brno, , Czech Republic
Brno, , Czech Republic
Brno, , Czech Republic
Brumov, , Czech Republic
Bruntal, , Czech Republic
Bustehrad, , Czech Republic
Bustehrad, , Czech Republic
Bystrice Nad Pernstejnem, , Czech Republic
Bystrice Nad Pernstejnem, , Czech Republic
C. Trebova, , Czech Republic
Ceske Budejovice, , Czech Republic
Ceske Budejovice, , Czech Republic
Ceske Budejovice, , Czech Republic
Ceske Budejovice, , Czech Republic
Ceske Budejovice, , Czech Republic
Ceske Budejovice, , Czech Republic
Cheb, , Czech Republic
Decin, , Czech Republic
Decin, , Czech Republic
Decin, , Czech Republic
Decin, , Czech Republic
Decin, , Czech Republic
Hadacka, , Czech Republic
Havirov,Ostrava, , Czech Republic
Havirov, , Czech Republic
Horni Slavkov, , Czech Republic
Hradec Kralove, , Czech Republic
Hradec Kralove, , Czech Republic
Hranice U Asa, , Czech Republic
Hranice, , Czech Republic
Hranice, , Czech Republic
Jihlava, , Czech Republic
Karlovy Vary, , Czech Republic
Kdyne, , Czech Republic
Kladno, , Czech Republic
Kladno, , Czech Republic
Koprivnice, , Czech Republic
Krnov, , Czech Republic
Kunovice, , Czech Republic
Kutna Hora, , Czech Republic
Litomysl, , Czech Republic
Litvinov, , Czech Republic
Louny, , Czech Republic
Lovosice, , Czech Republic
Malsice, , Czech Republic
Mlada Boleslav, , Czech Republic
Mlada Boleslav, , Czech Republic
Mnichovo Hradiste, , Czech Republic
Novy Jicin, , Czech Republic
Novy Jicin, , Czech Republic
Nymburk, , Czech Republic
Olomouc, , Czech Republic
Olomouc, , Czech Republic
Olomouc, , Czech Republic
Olomouc, , Czech Republic
Orlova, , Czech Republic
Ostrava, , Czech Republic
Ostrava, , Czech Republic
Ostrava, , Czech Republic
Ostrava, , Czech Republic
Ostrava, , Czech Republic
Pardubice, , Czech Republic
Pardubice, , Czech Republic
Pardubice, , Czech Republic
Pardubice, , Czech Republic
Pardubice, , Czech Republic
Plasy, , Czech Republic
Plzen, , Czech Republic
Plzen, , Czech Republic
Plzen, , Czech Republic
Podebrady, , Czech Republic
Prachatice, , Czech Republic
Prague 10, , Czech Republic
Prague 2, , Czech Republic
Prague 2, , Czech Republic
Prague 3, , Czech Republic
Prague 4, , Czech Republic
Prague 4, , Czech Republic
Prague 4, , Czech Republic
Prague 5, , Czech Republic
Prague 5, , Czech Republic
Prague 6, , Czech Republic
Prague 6, , Czech Republic
Prague 6, , Czech Republic
Prague 8, , Czech Republic
Prague 8, , Czech Republic
Prague 8, , Czech Republic
Prague 8, , Czech Republic
Prague 9, , Czech Republic
Prague 9, , Czech Republic
Prague 9, , Czech Republic
Prelouc, , Czech Republic
Prelouc, , Czech Republic
Pribram, , Czech Republic
Rokycany, , Czech Republic
Slany, , Czech Republic
Slatinany, , Czech Republic
Smrzovka, , Czech Republic
Stara Paka, , Czech Republic
Stare Mesto, , Czech Republic
Stare Mesto, , Czech Republic
Sternberk, , Czech Republic
Svitavy, , Czech Republic
Tabor, , Czech Republic
Teplice, , Czech Republic
Tranovice, , Czech Republic
Trebic, , Czech Republic
Trinec, , Czech Republic
Trinec, , Czech Republic
Trinec, , Czech Republic
Trutnov, , Czech Republic
Turnov, , Czech Republic
Uherske Hradiste, , Czech Republic
Uherske Hradiste, , Czech Republic
Usti Nad Labem, , Czech Republic
Usti Nad Labem, , Czech Republic
Valasske Mezirici, , Czech Republic
Vyskov, , Czech Republic
Vyskov, , Czech Republic
Zabreh, , Czech Republic
Zamberk, , Czech Republic
Zdar Nad Sazavou, , Czech Republic
Zdar Nad Sazavou, , Czech Republic
Zlonice, , Czech Republic
Patients applied
Trial Officials
Adam Hloska, M.D.
Study Director
Abbott
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials